Sanofi

Overview

Global biopharmaceutical company (formerly including Bayer Vaccines) operating a pilot lights-out synthetic lab and advancing continuous downstream processing, with patient affordability as a stated development obligation Sanofi operates a pilot autonomous synthetic chemistry lab spanning France and the US, where scientists can remotely order experiments and receive results the next day, demonstrating lights-out lab viability for synthetic chemistry ahead of biologics. Sanofi advocates for process simplification through continuous downstream processing as a means of enabling global manufacturing standardization: real-time data collected centrally can verify that a process runs identically across geographically distributed sites. (Segment 6 (25:00-30:00))